Covariation of amino acid positions in HIV-1 protease

被引:64
|
作者
Hoffman, NG
Schiffer, CA
Swanstrom, R
机构
[1] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27599 USA
[2] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA
关键词
protease; HIV-1; resistance; covariation; mutual information; protease inhibitor; variation;
D O I
10.1016/S0042-6822(03)00484-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have examined patterns of sequence variability for evidence of linked sequence changes in HIV-1 subtype B protease using translated sequences from protease inhibitor (PI) treated and untreated subjects downloaded from the Stanford HIV RT and Protease Sequence Database (http://hivdb.stanford.edu). The final data set size wits 648 sequences from untreated subjects (notx) and 531 for PI-treated subjects (tx). Each subject was uniquely represented by a single sequence. Mutual information was calculated for all pairwise comparisons of positions with nonconsensus amino acids in at least 5% of sequences; significance of pairwise association was assessed using permutation tests. In addition pairs of positions were assessed for linkage by comparing the observed occurrences of amino acid combinations to expected values. The mutual information statistic indicated linkage between nine pairs of sites in the untreated data set (10:93, 12:19, 35:38, 37:4 1, 62:71, 63:64, 71:77, 71:93, 77:93). Strong statistical support for linkage in the treated data set was seen for 32 pairs, eight involving position 10:7 involving position 71, with the rest being 12:19, 15:77, 20:36, 30:88, 35:36, 35:37, 36:62, 36:77, 46:82, 46:84, 48:54, 48:82, 54:82, 63:64, 63:90, 73:90, 77:93, and 84:90. Most associations were positive, although negative associations were seen for five pairs of interactions. Structural proximity suggests that numerous pairs may interact within a local environment. These interactions include two distinct clusters around 36/77 and 71/93. While some of these interactions may reflect fortuitous linkage in heavily treated subjects with many resistance mutations, others will likely represent important cooperative interactions that are amenable to experimental validation. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:536 / 548
页数:13
相关论文
共 50 条
  • [31] Cell killing by HIV-1 protease
    Blanco, R
    Carrasco, L
    Ventoso, I
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) : 1086 - 1093
  • [32] Endothiopeptide inhibitors of HIV-1 protease
    Yao, S
    Zutshi, R
    Chmielewski, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (06) : 699 - 704
  • [33] Dimerization inhibitors of HIV-1 protease
    Boggetto, N
    Reboud-Ravaux, M
    BIOLOGICAL CHEMISTRY, 2002, 383 (09) : 1321 - 1324
  • [34] Rigidity analysis of HIV-1 protease
    Heal, J. W.
    Wells, S. A.
    Jimenez-Roldan, E.
    Freedman, R. F.
    Roemer, R. A.
    CONDENSED MATTER AND MATERIALS PHYSICS CONFERENCE (CMMP10), 2011, 286
  • [35] HIV-1 protease inhibitors in development
    Rusconi, S
    Catamancio, SL
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (03) : 387 - 395
  • [36] PURIFICATION OF RECOMBINANT HIV-1 PROTEASE
    MARGOLIN, N
    DEE, A
    MEI, L
    VLAHOS, CJ
    PREPARATIVE BIOCHEMISTRY, 1991, 21 (2-3): : 163 - 173
  • [37] The active site of HIV-1 protease
    Mager, PP
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (04) : 348 - 353
  • [38] Adaptability and flexibility of HIV-1 protease
    Kumar, M
    Hosur, MV
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (06): : 1231 - 1239
  • [39] COMPLETE MUTAGENESIS OF THE HIV-1 PROTEASE
    LOEB, DD
    SWANSTROM, R
    EVERITT, L
    MANCHESTER, M
    STAMPER, SE
    HUTCHISON, CA
    NATURE, 1989, 340 (6232) : 397 - 400
  • [40] A folding inhibitor of the HIV-1 protease
    Broglia, RA
    Provasi, D
    Vasile, F
    Ottolina, G
    Longhi, R
    Tiana, G
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2006, 62 (04) : 928 - 933